Organization | Botswana Ministry of Health

Botswana Ministry of Health Report issue

Government Phase 3 Phase 4

Founded: Gaborone Botswana (1966)

Organization Overview

First Clinical Trial

2002

NCT00197613

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

Botswana Ministry of Health

Active Ingredients

Drugs in Phase 4 Trials (4)

abacavir (ziagen) (1 trial)

dolutegravir (tivicay) (1 trial)

isoniazid (nydrazid) (1 trial)

lamivudine (epivir) (2 trials)

Drugs in Phase 3 Trials (8)

chadox1 (1 trial)

didanosine (videx) (1 trial)

efavirenz (sustiva) (1 trial)

emtricitabine (emtriva) (2 trials)

nevirapine (viramune) (1 trial)

stavudine (zerit) (1 trial)

tenofovir (viread) (3 trials)

zidovudine (retrovir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 3)

HIV Infections (Phase 3)

Infections (Phase 3)

Tuberculosis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 12